Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Defining the epigenomic landscape of rare pediatric brain tumors
FY 2016-17
Summary
Embryonal tumors with multilayered rosettes (ETMR) are very aggressive pediatric brain tumors. They affect mainly children under the age of two years and are almost always fatal. These tumors do not respond to currently available treatments and frequently reoccur following complete tumor resection. ETMRs have only recently been described and more insight into the driving force of this lethal disease is desperately needed. Genomic analysis of ETMRs has identified only one genetic alteration, the fusion of the TTYH1 promoter to the C19MC miRNA cluster. This genetic lesion has provided little insight into tumorigenesis and can not be used as a therapeutic target. Based on the paucity of genetic events in this tumor, I hypothesize that epigenetic alterations are the driving force for tumorigenesis in ETMRs. I propose to characterize the epigenomic landscape of primary and recurrent tumors in order to identify the mechanisms this disease uses to progress and attain increased aggressiveness. My work will also focus on the role of LIN28 in shaping the epigenome of ETMRs. LIN28 is overexpressed in ETMRs but is currently only being used as a diagnostic tool. LIN28 is involved in embryonic development and tumorigenesis but its functional role in ETMR etiology has not been elucidated. My lab has developed the only in vitro model of ETMR derived from primary patient tissue. Our primary cell culture will be used alongside primary patient tissue for ChIP-seq and ATAC-seq experiments in order to map changes in the epigenomic landscape caused by LIN28. My research will contribute to our knowledge of these rare pediatric brain tumors and ultimately aide in the development of a cure.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367074
Name
Chute Mary
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Defining the epigenomic landscape of rare pediatric brain tumors
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atac-Seq; Brain Tumor; Cancer; Chromatin; Chromatin Immunoprecipitation; Embryonal Tumor With Multilayered Rosettes; Epigenetics; Epigenomics; Etmr; Histones
Abstract
Embryonal tumors with multilayered rosettes (ETMR) are very aggressive pediatric brain tumors. They affect mainly children under the age of two years and are almost always fatal. These tumors do not respond to currently available treatments and frequently reoccur following complete tumor resection. ETMRs have only recently been described and more insight into the driving force of this lethal disease is desperately needed. Genomic analysis of ETMRs has identified only one genetic alteration, the fusion of the TTYH1 promoter to the C19MC miRNA cluster. This genetic lesion has provided little insight into tumorigenesis and can not be used as a therapeutic target. Based on the paucity of genetic events in this tumor, I hypothesize that epigenetic alterations are the driving force for tumorigenesis in ETMRs. I propose to characterize the epigenomic landscape of primary and recurrent tumors in order to identify the mechanisms this disease uses to progress and attain increased aggressiveness. My work will also focus on the role of LIN28 in shaping the epigenome of ETMRs. LIN28 is overexpressed in ETMRs but is currently only being used as a diagnostic tool. LIN28 is involved in embryonic development and tumorigenesis but its functional role in ETMR etiology has not been elucidated. My lab has developed the only in vitro model of ETMR derived from primary patient tissue. Our primary cell culture will be used alongside primary patient tissue for ChIP-seq and ATAC-seq experiments in order to map changes in the epigenomic landscape caused by LIN28. My research will contribute to our knowledge of these rare pediatric brain tumors and ultimately aide in the development of a cure.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chute, Mary
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~